Major Article Contributions by our Indian authors in Bentham Science Publishers Journal, Anti-Cancer Agents n Medicinal Chemistry

anti-canceragentsJournal Name: Anti-Cancer Agents in Medicinal Chemistry

Article Title: Platinum Compounds: A Hope for Future Cancer Chemotherapy

Author(s): Imran Ali, Waseem A. Wani, Kishwar Saleem and Ashanul Haque


The discovery of cis-platin and its second and third generation analogues created a hope in cancer chemotherapy. Cis-platin and its second generation analogue carboplatin have been used for the treatment of some cancers from a long time. The third generation analogues have superior anti-cancer profiles for curing a few cancers. Unfortunately, certain side effects such as renal impairment, neurotoxicity and ototoxicity etc. are associated with these drugs. But, combination therapy makes these analogues more effective with fewer side effects. In addition, the results of some ongoing clinical trials will make the safety profile clear in near future. The present article describes the current status of cis-platin and its analogues in cancer chemotherapy. In addition, special emphasis has been made on cis-platin discovery, development of second (carboplatin, oxaliplatin, nedaplatin) and third (lobaplatin, heptalatin) generation analogues, comparison of their chemotherapies, mechanism of action, therapeutic status, recent developments and chronology. Moreover, attempts have been made to describe the future perspectives of these drugs in the cancer treatment.

For more details, please click:

Open Access Pluss Explained

Through Open Access Plus, authors of accepted papers are given the option of paying an open access publication charge to make their paper freely available online immediately via the journal website, meaning that readers will not need a journal subscription to view open access content. If an author does not choose to pay the open access publication charge, their article will be published with the standard subscription-based access at no cost. Open access plus articles will be clearly indicated on the journal’s online contents access pluss at bsp4
Bentham Science offers 40% discount on open access fees to their Editors, Board members and those authors who have contributed more than two articles in Bentham Science publications.
In case you are interested in publishing your article as open access, please email to at your earliest.
When you choose Open Access plus, your and your readers’ benefits are
  • Your article is freely available online.
  • Easy compliance with open access mandates.
  • Final version can be re-used and immediately deposited in any repository.
  • Automatic export triggered to PubMed Central/Europe PubMed Central (PMC).








Podcast: Ride or Die; Therapeutic Interventions for Retaliatory Violence Among Youth

Violence among youth continues to be a serious public health concern across the nation. Researchers have increasingly argued that effective violence preventions efforts and practice must consider the lived experience of youth. Retaliatory violence (i.e., violence in response to a perceived attack or threat) is a major concern and risk issue for young people, and has been increasingly linked to lethal violence. Primary care and mental health practitioners can play a vital role in helping young people who struggle with retaliatory violence to understand the emotions and decisions associated with these situations. However, there is limited research advising clinicians on how to help youth negotiate these issues in treatment.

Watch more podcasts on Bentham Science YouTube Channel

Recently Published Issue of the Journal Current Neurovascular Research

Current Neurovascular Research provides a cross platform for the publication of scientifically rigorous research that addresses disease mechanisms of both neuronal and vascular origins in neuroscience. The journal serves as an international forum publishing novel and original work as well as timely neuroscience research reviews in the disciplines of cell developmental disorders, plasticity, and degeneration that bridge the gap between basic science research and clinical discovery. Current Neurovascular Research emphasizes the elucidation of disease mechanisms, both cellular and molecular, which can impact the development of unique therapeutic strategies for neuronal and vascular disorders.

Following are the articles from the journal Current Neurovascular Research, 12 Issue 3:

: MicroRNAs and Stem Cells to the Rescue

Author(s): Kenneth Maiese


Article: Differential Regulation of microRNAs in Patients with Ischemic Stroke

Author(s): Sheng-Hua Li, Sheng-You Su and Jing-Li Liu


Article: Combination of Local Transplantation of In Vitro Bone-marrow Stromal Cells and Pulsed Electromagnetic Fields Accelerate Functional Recovery of Transected Sciatic Nerve Regeneration: A Novel Approach in Transected Nerve Repair

Author(s): Rahim Mohammadi and Sirvan Mahmoodzadeh


Article: Radix Angelica Sinensis Promotes Synaptic Plasticity During Cognitive Recovery in Chronically Stressed Rats

Author(s): Min Deng, Huimin Sun, Jun Shen, Yuanteng Fan, Lei Zhang and Junjian Zhang


Article: Neuroprotective Effects of Agomelatine and Vinpocetine Against Chronic Cerebral Hypoperfusion Induced Vascular Dementia

Author(s): Surbhi Gupta, Prabhat Singh, Brij Mohan Sharma and Bhupesh Sharma


Article: Interleukin-1β Receptor Antagonism Prevents Cognitive Impairment Following Experimental Bacterial Meningitis

Author(s): Tatiana Barichello, Jaqueline S. Generoso, Lutiana R. Simoes, Vladislav G. Sharin, Renan A. Ceretta, Diogo Dominguini, Clarissa M. Comim, Marcia C. Vilela, Antonio Lucio Teixeira and Joao Quevedo


Article: Rufinamide Improves Functional and Behavioral Deficits via Blockade of Tetrodotoxin-Resistant Sodium Channels in Diabetic Neuropathy

Author(s): Shivsharan B. Kharatmal, Jitendra N. Singh and Shyam S. Sharma


Article: Outcome Prediction after Non-aneurysmal Non-traumatic Subarachnoid Hemorrhage

Author(s): Ramazan Jabbarli, Matthias Reinhard, Roland Roelz, Mukesch Shah, Wolf-Dirk Niesen, Klaus Kaier, Christian Taschner, Astrid Weyerbrock and Vera Van Velthoven


Article: Perfusion-diffusion Mismatch Predicts Early Neurological Deterioration in Anterior Circulation Infarction without Thrombolysis

Author(s): Chia-Yu Hsu, Chun-Yu Cheng, Yuan-Hsiung Tsai, Jiann-Der Lee, Jen-Tsung Yang, Hsu-Huei Weng, Leng-Chieh Lin, Ying-Chih Huang, Meng Lee, Ming-Hsueh Lee, Chih-Ying Wu, Ya-Hui Lin, Huan-Lin Hsu, Hsin-Ta Yang, Yi-Ting Pan and Yen-Chu Huang


Article: Acute and Chronic Treatments with Quetiapine Increase Mitochondrial Respiratory Chain Complex Activity in the Rat Brain

Author(s): Zuleide M. Ignacio, Gislaine Z. Reus, Helena M. Abelaira, Stephanie E. Titus, Anelise S. Carlessi, Jaine R. da Luz, Beatriz I. Matias, Livia Bruchchen, Milena Carvalho-Silva, Lara M. Gomes, Joyce Rebelo, Emilio L. Streck and Joao Quevedo


Article: VEGF Signaling Regulates Cofilin and the Arp2/3-complex within the Axonal Growth Cone

Author(s): Matthias Dumpich, Hans Georg Mannherz and Carsten Theiss


For details, please visit:

Free Online Trial is active in the following Italian Universities:


University of Eastern Piedmont

The University of Eastern Piedmont Amedeo Avogadro (Italian: Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, UNIPMN or UPO) is a university located in Alessandria, Novara and Vercelli, Italy. It was founded in 1998 and is organized in 7 faculties.

Universita’ degli Studi di Napoli Federico II

The University of Naples Federico II (Italian: Università degli Studi di Napoli Federico II) is a university located in Naples, Italy. It was founded in 1224 and is organized into 13 faculties. It is the world’s oldest state university and one of the oldest academic institutions in continuous operation.

Federico II is the third University in Italy by number of students enrolled, despite its huge dimensions it still represents one of the best Universities in Italy being an excellence in particular for research; in 2015 it was ranked among the first 100 universities in the world by citations per paper. The university is named after its founder Frederick II.

free trial2
Free Online Trial Request form:
Email for further assistance:

High Impact Factor Journal:::Recent Patents on Nanotechnology

Recent Patents on Nanotechnology publishes review and research articles, and guest edited thematic issues on recent patents in the field of nanotechnology. A selection of important and recent patents on nanotechnology is also included in the journal. The journal is essential reading for all researchers involved in nanotechnology.

Ranking and Category:

  • 56th of 259 in Materials Science, Multidisciplinary
  • 34th of 79 in Nanoscience & Nanotechnology
  • 30th of 143 in Physics, Applied


most open ccesstrial request